AstraZeneca and its development ... with a history of asthma exacerbations and uncontrolled asthma receiving currently approved inhaled treatment versus placebo. The trial showed annual asthma ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a ...

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been ... and research activities from: AstraZeneca, Boehringer Ingelheim ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender for market share in COPD. Key opinion leaders (KOLs) interviewed by ...

A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...